EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, BioLargo's enterprise value is $102.34 Mil.
BioLargo's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $12.23 Mil. Therefore, BioLargo's EV-to-Revenue for today is 8.37.
The historical rank and industry rank for BioLargo's EV-to-Revenue or its related term are showing as below:
BLGO'
s EV-to-Revenue Range Over the Past 10 Years
Min: 3.81 Med: 32.15 Max: 527.38
Current: 8.37
During the past 13 years, the highest EV-to-Revenue of BioLargo was 527.38. The lowest was 3.81. And the median was 32.15.
BLGO's EV-to-Revenue is ranked worse than 92.33% of 1539
companies
in the Chemicals industry
Industry Median: 1.53
vs BLGO: 8.37
As of today (2024-04-28), BioLargo's stock price is $0.3525.
BioLargo's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.04. Therefore, BioLargo's PS Ratio for today is 8.39.
BioLargo EV-to-Revenue Historical Data
The historical data trend for BioLargo's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of BioLargo's EV-to-Revenue
For the Chemicals subindustry, BioLargo's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioLargo's EV-to-Revenue Distribution in the Chemicals Industry
For the Chemicals industry and Basic Materials sector, BioLargo's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where BioLargo's EV-to-Revenue falls into.
BioLargo's current Enterprise Value is $102.34 Mil.
BioLargo's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $12.23 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioLargo's share price for today is $0.3525.
BioLargo's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.04.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioLargo EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of BioLargo's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
BioLargo Inc invents, develops, and commercializes platform technologies to solve challenging environmental problems like PFAS contamination, advanced water, and wastewater treatment, industrial odor, and VOC control, air quality control, and infection control. The company holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. BioLargo invents or acquires novel technologies and develops them to maturity through its operating subsidiaries. It monetizes through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation, and/or the sale of the IP. The firm's technologies are commercially available and are advancing as disrupters in their respective markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BLGO has been successfully added to your 